{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:44:49Z","timestamp":1790379889967,"version":"4.1.0"},"reference-count":63,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2014Next Generation EU","award":["PNRR-MAD-2022\u201312375740 M6C2"],"award-info":[{"award-number":["PNRR-MAD-2022\u201312375740 M6C2"]}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Psoriasis is a chronic inflammatory skin disease whose pathogenesis involves not only cutaneous inflammation but also intestinal dysbiosis and oxidative stress (OxS). Monoclonal antibodies targeting interleukin (IL)-17 and IL-23 have demonstrated significant immunomodulatory effects; however, their impact on systemic parameters requires further investigation. We conducted a study on 33 patients with plaque psoriasis treated with anti-IL-17 or anti-IL-23 monoclonal antibodies. Dermatological parameters (Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI)), biomarkers of intestinal dysbiosis (trimethylamine-N-oxide (TMAO)) and OxS (reactive oxygen metabolites (d-ROMs) and oxidized LDL (oxLDL)) were evaluated. Anthropometric, metabolic, and adipose-derived hormonal parameters (adipokines) were also monitored. After 16 weeks of therapy, significant improvements were observed in PASI and DLQI scores (p &lt; 0.001). TMAO levels were significantly reduced (p = 0.02), as were d-ROMs and oxLDL (p &lt; 0.001). No significant changes were found in weight, body mass index, lipid profile, or adipokine levels (visfatin, leptin and adiponectin). Our data indicate that monoclonal antibody therapy not only improves psoriasis severity but also exerts beneficial effects on systemic biomarkers of dysbiosis and OxS, independent of metabolic or hormonal changes. These findings suggest a systemic mechanism of action, supporting a multifactorial therapeutic effect with potential implications for the prevention of cardiovascular risk.<\/jats:p>","DOI":"10.3390\/life15111703","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:47:58Z","timestamp":1762177678000},"page":"1703","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-662X","authenticated-orcid":false,"given":"Giuseppe","family":"Annunziata","sequence":"first","affiliation":[{"name":"Dipartimento di Psicologia e Scienze della Salute, Universit\u00e0 Telematica Pegaso, Via Porzio, Centro Direzionale Isola F2, 80143 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-3262","authenticated-orcid":false,"given":"Emanuele","family":"Scala","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mercurio","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sanna","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0488-2341","authenticated-orcid":false,"given":"Anna","family":"Dattolo","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pagnanelli","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Lolli","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Belli","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Moretta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3211-4307","authenticated-orcid":false,"given":"Silvia","family":"Savastano","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Endocrinologia, Diabetologia ed Andrologia, Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, 80131 Naples, Italy"},{"name":"Centro Italiano per la Cura e il Benessere del Paziente con Obesit\u00e0 (C.I.B.O), University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-4931","authenticated-orcid":false,"given":"Giovanna","family":"Muscogiuri","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Endocrinologia, Diabetologia ed Andrologia, Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, 80131 Naples, Italy"},{"name":"Centro Italiano per la Cura e il Benessere del Paziente con Obesit\u00e0 (C.I.B.O), University of Naples Federico II, 80131 Naples, Italy"},{"name":"Cattedra Unesco \u201cEducazione Alla Salute E Allo Sviluppo Sostenibile\u201d, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-2254","authenticated-orcid":false,"given":"Maria","family":"Maisto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8734-4249","authenticated-orcid":false,"given":"Roberto","family":"Ciampaglia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-5022","authenticated-orcid":false,"given":"Vincenzo","family":"Piccolo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0251-9936","authenticated-orcid":false,"given":"Gian Carlo","family":"Tenore","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-6833","authenticated-orcid":false,"given":"Cristina","family":"Albanesi","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-6783","authenticated-orcid":false,"given":"Stefania","family":"Madonna","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-456X","authenticated-orcid":false,"given":"Luigi","family":"Barrea","sequence":"additional","affiliation":[{"name":"Dipartimento di Psicologia e Scienze della Salute, Universit\u00e0 Telematica Pegaso, Via Porzio, Centro Direzionale Isola F2, 80143 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"ref_1","first-page":"14","article-title":"A brief synopsis of monoclonal antibody for the treatment of various groups of diseases","volume":"10","author":"Puthenpurail","year":"2021","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"ref_2","unstructured":"Andronescu, E., and Grumezescu, A.M. (2017). Therapeutic Use of Monoclonal Antibodies: General Aspects and Challenges for Drug Delivery. Nanostructures for Drug Delivery, Elsevier."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/CCID.S462797","article-title":"The Role of Interleukin 23\/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials","volume":"17","author":"Potestio","year":"2024","journal-title":"CCID"},{"key":"ref_4","first-page":"1363","article-title":"Biologics That Inhibit the Th17 Pathway and Related Cytokines to Treat Inflammatory Disorders","volume":"17","author":"Balato","year":"2017","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","article-title":"Psoriasis","volume":"11","author":"Armstrong","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","first-page":"1","article-title":"Update Aetiopathogenesis and Treatment of Psoriasis: A Literature Review","volume":"4","year":"2023","journal-title":"JDR"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/etm.2022.11124","article-title":"Update on the Etiopathogenesis of Psoriasis (Review)","volume":"23","author":"Branisteanu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Caiazzo, G., Fabbrocini, G., Di Caprio, R., Raimondo, A., Scala, E., Balato, N., and Balato, A. (2018). Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01668"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of Psoriasis as a Systemic Disease: What Is the Evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Scala, E., Mercurio, L., Albanesi, C., and Madonna, S. (2024). The Intersection of the Pathogenic Processes Underlying Psoriasis and the Comorbid Condition of Obesity. Life, 14.","DOI":"10.3390\/life14060733"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Secchiero, P., Rimondi, E., Marcuzzi, A., Longo, G., Papi, C., Manfredini, M., Fields, M., Caruso, L., Di Caprio, R., and Balato, A. (2024). Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158098"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/1346-8138.14647","article-title":"Intestinal Barrier Integrity in Patients with Plaque Psoriasis","volume":"45","author":"Sikora","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Valentini, V., Silvestri, V., Bucalo, A., Marraffa, F., Risicato, M., Grassi, S., Pellacani, G., Ottini, L., and Richetta, A.G. (2022). A Possible Link between Gut Microbiome Composition and Cardiovascular Comorbidities in Psoriatic Patients. JPM, 12.","DOI":"10.3390\/jpm12071118"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e41672","DOI":"10.1016\/j.heliyon.2025.e41672","article-title":"New Horizons in the Treatment of Psoriasis: Modulation of Gut Microbiome","volume":"11","author":"Memariani","year":"2025","journal-title":"Heliyon"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., and Xing, Y. (2019). Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01360"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Caradonna, E., Abate, F., Schiano, E., Paparella, F., Ferrara, F., Vanoli, E., Difruscolo, R., Goffredo, V.M., Amato, B., and Setacci, C. (2025). Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health. Metabolites, 15.","DOI":"10.3390\/metabo15040220"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Budoff, M.J., De Oliveira Otto, M.C., Li, X.S., Lee, Y., Wang, M., Lai, H.T.M., Lemaitre, R.N., Pratt, A., Tang, W.H.W., and Psaty, B.M. (2025). Trimethylamine-N-Oxide (TMAO) and Risk of Incident Cardiovascular Events in the Multi Ethnic Study of Atherosclerosis. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-05903-3"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Stec, A., Sikora, M., Maciejewska, M., Paralusz-Stec, K., Michalska, M., Sikorska, E., and Rudnicka, L. (2023). Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases. IJMS, 24.","DOI":"10.3390\/ijms24043494"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2023116","DOI":"10.5826\/dpc.1302a116","article-title":"The Relationship of Serum Trimethylamine N-Oxide Levels with Carotid Intima-Media Thickness and Disease Activity in Psoriasis Patients","volume":"13","author":"Zekey","year":"2023","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s13555-021-00547-3","article-title":"Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study","volume":"11","author":"Sikora","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_21","first-page":"331","article-title":"TMAO Promotes Disorders of Lipid Metabolism in Psoriasis","volume":"50","author":"Li","year":"2025","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_22","first-page":"481","article-title":"Choline Metabolite, Trimethylamine N-Oxide (TMAO), Is Associated with Inflammation in Psoriatic Arthritis","volume":"37","author":"Coras","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e15622","DOI":"10.1111\/dth.15622","article-title":"PSES Study Group Sociodemographic, Clinical and Therapeutic Factors as Predictors of Life Quality Impairment in Psoriasis: A Cross-sectional Study in Italy","volume":"35","author":"Scala","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ihtatho, D., Fadzil, M.H.A., Affandi, A.M., and Hussein, S.H. (2007, January 22\u201326). Area Assessment of Psoriasis Lesion for PASI Scoring. Proceedings of the 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Lyon, France.","DOI":"10.1109\/IEMBS.2007.4353072"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Barrea, L., Annunziata, G., Muscogiuri, G., Di Somma, C., Laudisio, D., Maisto, M., De Alteriis, G., Tenore, G.C., Colao, A., and Savastano, S. (2018). Trimethylamine-N-Oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome. Nutrients, 10.","DOI":"10.3390\/nu10121971"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40257-024-00857-0","article-title":"Managing the Patient with Psoriasis and Metabolic Comorbidities","volume":"25","author":"Bellinato","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_27","first-page":"119","article-title":"Psoriasis and Comorbidities: Links and Risks","volume":"7","author":"Ni","year":"2014","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Scala, E., Megna, M., Amerio, P., Argenziano, G., Babino, G., Bardazzi, F., Bianchi, L., Caldarola, G., Campanati, A., and Cannav\u00f2, S.P. (2020). Patients\u2019 Demographic and Socioeconomic Characteristics Influence the Therapeutic Decision-Making Process in Psoriasis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0237267"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7294541","DOI":"10.1155\/dth\/7294541","article-title":"Therapeutic Strategies and Decision-Making to Optimize Psoriasis Treatment: A French National Survey Based on Virtual Case Vignettes","volume":"2025","author":"Jouan","year":"2025","journal-title":"Dermatol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.intimp.2018.06.020","article-title":"Efficacy and Safety of Biologics Targeting IL-17 and IL-23 in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"62","author":"Cui","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/09546634.2017.1422591","article-title":"A Systematic Review and Meta-Analysis of the Efficacy and Safety of the Interleukin (IL)-12\/23 and IL-17 Inhibitors Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab and Tildrakizumab for the Treatment of Moderate to Severe Plaque Psoriasis","volume":"29","author":"Bilal","year":"2018","journal-title":"J. Dermatol. Treat."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Radaschin, D.S., Iancu, A.V., Ionescu, A.M., Gurau, G., Niculet, E., Bujoreanu, F.C., Beiu, C., Tatu, A.L., and Popa, L.G. (2024). Comparative Analysis of the Cutaneous Microbiome in Psoriasis Patients and Healthy Individuals\u2014Insights into Microbial Dysbiosis: Final Results. IJMS, 25.","DOI":"10.3390\/ijms251910583"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zhao, H., Shang, L., Zhang, Y., Liang, Z., Wang, N., Zhang, Q., Gao, C., and Luo, J. (2024). IL-17A Inhibitors Alleviate Psoriasis with Concomitant Restoration of Intestinal\/Skin Microbiota Homeostasis and Altered Microbiota Function. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1344963"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1097\/CM9.0000000000003223","article-title":"Influence of Biological Treatments on Intestinal Microbiota of Psoriasis Patients","volume":"137","author":"Wen","year":"2024","journal-title":"Chin. Med. J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Huang, W., Geng, Y., Gong, J., and Wu, W. (2025). The Impact of IL-17A Inhibitors on Scalp and Gut Microbiota in Psoriasis. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1623003"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Huang, Y.-H., Chang, L.-C., Chang, Y.-C., Chung, W.-H., Yang, S.-F., and Su, S.-C. (2023). Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors. IJMS, 24.","DOI":"10.3390\/ijms24054568"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-Producing Cells in Protection versus Pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/odi.12598","article-title":"IL-17: Overview and Role in Oral Immunity and Microbiome","volume":"23","author":"Abusleme","year":"2017","journal-title":"Oral. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/apt.70139","article-title":"Risk of De Novo Inflammatory Bowel Disease in Patients with Psoriasis and Psoriatic Arthritis Treated with IL\u201417A Inhibitors: A Population-Based Study","volume":"62","author":"Alsakarneh","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cpt.2155","article-title":"IL-17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in Vigibase","volume":"110","author":"Petitpain","year":"2021","journal-title":"Clin. Pharma Ther."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Deng, Z., Wang, S., Wu, C., and Wang, C. (2023). IL-17 Inhibitor-Associated Inflammatory Bowel Disease: A Study Based on Literature and Database Analysis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1124628"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41575-023-00768-1","article-title":"Alimentiv Translational Research Consortium (ATRC) IL-12 and IL-23 Pathway Inhibition in Inflammatory Bowel Disease","volume":"20","author":"Verstockt","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wang, S., Sun, H., Wang, Q., and Xiao, H. (2025). Efficacy and Safety of IL-23 P19 Inhibitors in the Treatment for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1490667"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e12993","DOI":"10.1111\/obr.12993","article-title":"Gut Microbiota-derived Metabolite Trimethylamine N-oxide (TMAO) Potentially Increases the Risk of Obesity in Adults: An Exploratory Systematic Review and Dose-response Meta-Analysis","volume":"21","author":"Dehghan","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Belli, R., Dattolo, A., Sampogna, F., Gubinelli, E., Lulli, D., Moretta, G., Scala, E., Sanna, L., Megna, M., and Cannizzaro, M.V. (2025). Leptin: A Gender and Obesity-Related Marker Predictive of Metabolic Comorbidities and Therapeutic Response to Anti-IL-23 Biologic Drugs in Psoriatic Patients. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1607312"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.freeradbiomed.2009.06.033","article-title":"Oxidative Stress in the Pathogenesis of Psoriasis","volume":"47","author":"Zhou","year":"2009","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dobric\u0103, E.C., Cozma, M.A., G\u0103man, M.A., Voiculescu, V.M., and G\u0103man, A.M. (2022). The Involvement of Oxidative Stress in Psoriasis: A Systematic Review. Antioxidants, 11.","DOI":"10.3390\/antiox11020282"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0009-8981(99)00062-5","article-title":"The Significance of Autoantibodies against Oxidatively Modified Low-Density Lipoprotein (LDL) in Patients with Psoriasis","volume":"284","author":"Orem","year":"1999","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_49","first-page":"78454","article-title":"Accumulation of Oxidized Low-Density Lipoprotein in Psoriatic Skin and Changes of Plasma Lipid Levels in Psoriatic Patients","volume":"2007","author":"Tekin","year":"2007","journal-title":"Mediat. Inflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4103\/ijmr.IJMR_717_16","article-title":"Dyslipidaemia & Oxidative Stress in Patients of Psoriasis: Emerging Cardiovascular Risk Factors","volume":"146","author":"Asha","year":"2017","journal-title":"Indian J. Med. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E656","DOI":"10.1152\/ajpendo.2000.278.4.E656","article-title":"Protein Kinase C-Beta Mediates Lipoprotein-Induced Generation of PAI-1 from Vascular Endothelial Cells","volume":"278","author":"Ren","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000066685.13434.FA","article-title":"LOX-1, an Oxidized LDL Endothelial Receptor, Induces CD40\/CD40L Signaling in Human Coronary Artery Endothelial Cells","volume":"23","author":"Li","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0008-6363(02)00447-9","article-title":"Effects of Oxidised Low Density Lipoprotein on Dendritic Cells: A Possible Immunoregulatory Component of the Atherogenic Micro-Environment?","volume":"55","author":"Alderman","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/ilar.43.Suppl_1.S95","article-title":"ICH guidelines\u2014Implementation of the 3Rs (refinement, reduction, and replacement): Incorporating best scientific practices into the regulatory process","volume":"43","author":"Ohno","year":"2002","journal-title":"ILAR J."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Maisto, M., Schiano, E., Novellino, E., Piccolo, V., Iannuzzo, F., Salviati, E., Summa, V., Annunziata, G., and Tenore, G.C. (2022). Application of a Rapid and Simple Technological Process to Increase Levels and Bioccessibility of Free Phenolic Compounds in Annurca Apple Nutraceutical Product. Foods, 11.","DOI":"10.3390\/foods11101453"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Barrea, L., Muscogiuri, G., Pugliese, G., de Alteriis, G., Maisto, M., Donnarumma, M., Tenore, G.C., Colao, A., Fabbrocini, G., and Savastano, S. (2021). Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa). Nutrients, 13.","DOI":"10.3390\/nu13061997"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00417-014-2853-6","article-title":"Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15% and vitamin B12 eye drops","volume":"253","author":"Macri","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_58","first-page":"127","article-title":"A simple test to monitor oxidative stress","volume":"18","author":"Cesarone","year":"1999","journal-title":"Int. Angiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1163\/156856700X00769","article-title":"The radical cation of N,N-diethyl-paraphenylendiamine: A possible indicator of oxidative stress in biological samples","volume":"26","author":"Alberti","year":"2000","journal-title":"Res. Chem. Intermed."},{"key":"ref_60","first-page":"85","article-title":"Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease","volume":"86","author":"Trotti","year":"2001","journal-title":"Haematologica"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1515\/CCLM.2002.019","article-title":"Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation","volume":"40","author":"Gerardi","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Annunziata, G., Ciampaglia, R., Maisto, M., D\u2019Avino, M., Caruso, D., Tenore, G.C., and Novellino, E. (2021). Taurisolo\u00ae, a Grape Pomace Polyphenol Nutraceutical Reducing the Levels of Serum Biomarkers Associated With Atherosclerosis. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.697272"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12967-024-04853-0","article-title":"Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): An effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study","volume":"22","author":"Verde","year":"2024","journal-title":"J. Transl. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/11\/1703\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:19:03Z","timestamp":1762319943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/11\/1703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["life15111703"],"URL":"https:\/\/doi.org\/10.3390\/life15111703","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}